Profile
Laszlo Takacs is the founder of BioSystems International SAS, which was founded in 2004.
He held the title of Chief Operating & Scientific Officer from 2013 to 2014.
Dr. Takacs's former jobs include being a Principal at Amgen, Inc. and Pfizer (St. Louis).
He was also a Professor-Genomic Sciences at the University of Debrecen.
Dr. Takacs received his graduate and doctorate degrees from the Hungarian Academy of Sciences and his doctorate degree from Semmelweis University.
Former positions of Laszlo Takacs
| Companies | Position | End |
|---|---|---|
BioSystems International SAS
 BioSystems International SAS BiotechnologyHealth Technology Biosystems International is a biotechnology company engaged in protein biomarker R&D using a unique and proprietary monoclonal antibody based proteomics technology (mAb proteomics), leading to the development of: Novel blood-based diagnostics for cancer and chronic diseases through the use of its innovative mAb proteomics approach, BSI is poised to translate its discoveries into novel blood-based diagnostics products for the early detection of cancer, a number of chronic diseases, and cancer recurrence with its most advanced program in the area of lung cancer currently under development. | Founder | 2014-03-05 |
| University of Debrecen | Corporate Officer/Principal | - |
| AMGEN INC. | Corporate Officer/Principal | - |
Pfizer (St. Louis)
 Pfizer (St. Louis) BiotechnologyHealth Technology Part of Pfizer Inc., Pfizer (St. Louis) is a company that provides research services in prescription medicines for humans and animals. The company is based in Chesterfield, MO. | Corporate Officer/Principal | - |
Training of Laszlo Takacs
| Semmelweis University | Doctorate Degree |
| Hungarian Academy of Sciences | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| AMGEN INC. | Health Technology |
| Private companies | 2 |
|---|---|
BioSystems International SAS
BioSystems International SAS BiotechnologyHealth Technology Biosystems International is a biotechnology company engaged in protein biomarker R&D using a unique and proprietary monoclonal antibody based proteomics technology (mAb proteomics), leading to the development of: Novel blood-based diagnostics for cancer and chronic diseases through the use of its innovative mAb proteomics approach, BSI is poised to translate its discoveries into novel blood-based diagnostics products for the early detection of cancer, a number of chronic diseases, and cancer recurrence with its most advanced program in the area of lung cancer currently under development. | Health Technology |
Pfizer (St. Louis)
Pfizer (St. Louis) BiotechnologyHealth Technology Part of Pfizer Inc., Pfizer (St. Louis) is a company that provides research services in prescription medicines for humans and animals. The company is based in Chesterfield, MO. | Health Technology |
- Stock Market
- Insiders
- Laszlo Takacs
